United States approves Regeneron antibody treatment given to Trump

Regeneron Pharmaceuticals Inc.'s antibody cocktail received an emergency use authorization from USA drug regulators for treatment of early COVID-19 symptoms, adding to the expanding arsenal of therapies available to physicians.

For Coronavirus treatment, the United States drug regulator has given a go-ahead for usage of antibody therapy that was used to treat President Donald Trump.

The agency said the antibodies are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19.

Trial findings released by Regeneron in October showed the drug may help treat patients outside the hospital, reducing virus levels and the need for further medical care.

There's no way to know whether the Regeneron drug helped Trump recover; he received a host of treatments and most COVID-19 patients recover on their own.

The Food and Drug Administration authorized use of the Regeneron Pharmaceuticals Inc. drug to try to prevent hospitalization and worsening disease from developing in patients with mild-to-moderate symptoms.

Hearn outside cutline at RSM Classic
Zach Johnson (65) and Bronson Burgoon (67) are Streb's nearest challengers at 14 under. He said he enjoyed the weather that was "a little bit more Colombian" on Friday.

"Regeneron now expects to have REGEN-COV2 treatment doses ready for approximately 80,000 patients by the end of November, approximately 200,000 patients by the first week of January, and approximately 300,000 patients in total by the end of January 2021", the company said in a news release Saturday. Patients with other conditions like diabetes, cardiovascular disease or chronic kidney disease also qualify for the drug. Its decision comes as US cases, hospitalizations and deaths all trend upward.

As TheBlaze reported, Carson contracted COVID-19 about two weeks ago.

There are several monoclonal antibody treatments that are in the experimental phase of testing and have not been given an emergency use authorization by the FDA.

Last month, an antibody drug developed by Regeneron against the Ebola virus received full FDA approval, the next step after an EUA.

They then harvested the immune cells that made those antibodies and grew them in a lab, in order to create a mass treatment.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.